109960 — AP Healthcare Income Statement
0.000.00%
- KR₩73bn
- KR₩48bn
- KR₩16bn
Annual income statement for AP Healthcare, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10,319 | 8,416 | 9,598 | 16,007 | 16,400 |
Cost of Revenue | |||||
Gross Profit | 2,486 | 1,762 | 2,130 | 4,981 | 5,365 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 14,528 | 11,092 | 10,528 | 20,180 | 15,433 |
Operating Profit | -4,209 | -2,675 | -930 | -4,173 | 967 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8,225 | 2,647 | -5,261 | 5,578 | -26,340 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11,059 | 2,647 | -5,607 | 4,171 | -28,020 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 11,084 | 2,650 | -5,607 | 4,304 | -28,094 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 11,084 | 2,650 | -5,607 | 1,851 | -28,094 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 340 | 76.3 | -157 | 89.6 | -246 |
Dividends per Share |